An Overview of the Current and Novel Drugs for Alzheimer's Disease with Particular Reference to Anti-Cholinesterase Compounds

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|25|3121-3130

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.25, 2004-10, pp. : 3121-3130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease

By Martinez Ana   Castro Ana  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 1, 2006-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

Cholinesterase Inhibitors for Alzheimer's Disease

By Grutzendler J.   Morris J.C.  

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 41-52

Adis International

Access to resources Recommend Favorite

An Overview on Potential Neuroprotective Compounds for Management of Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 1006-1011

Bentham Science Publishers

Access to resources Recommend Favorite

Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

By Ashby Emma Louise   Kehoe Patrick G  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1229-1242

Informa Healthcare

Access to resources Recommend Favorite

Anti-inflammatory drugs: a hope for Alzheimer’s disease?

By Hüll M.   Lieb K.   Fiebich B.L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 671-683

Informa Healthcare

Access to resources Recommend Favorite